{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T20:13:57Z","timestamp":1771359237343,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,17]]},"DOI":"10.7759\/cureus.103785","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T19:34:01Z","timestamp":1771356841000},"source":"Crossref","is-referenced-by-count":0,"title":["Unequal Burdens: Exploring Racial Differences in Sarcoidosis-Related Deaths Due to Pulmonary Hypertension Versus Fibrosis in the United States (1999-2023)"],"prefix":"10.7759","author":[{"given":"Muhammed","family":"Umer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Faizan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fizzah Mohammad","family":"Hanif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salim","family":"Surani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60680-7","article-title":"Sarcoidosis","volume":"383","author":"Valeyre D","year":"2014","unstructured":"Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet PY, Muller-Quernheim J. Sarcoidosis. Lancet. 2014, 383:1155-67. 10.1016\/S0140-6736(13)60680-7","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.537382","article-title":"Sarcoidosis epidemiology: race matters","volume":"11","author":"Hena KM","year":"2020","unstructured":"Hena KM. Sarcoidosis epidemiology: race matters. Front Immunol. 2020, 11:537382. 10.3389\/fimmu.2020.537382","journal-title":"Front Immunol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2012.03.019","article-title":"Pulmonary manifestations of sarcoidosis","volume":"41","author":"Baughman RP","year":"2012","unstructured":"Baughman RP, Lower EE, Gibson K. Pulmonary manifestations of sarcoidosis. Presse Med. 2012, 41:289-302. 10.1016\/j.lpm.2012.03.019","journal-title":"Presse Med"},{"key":"ref4","unstructured":"WHO. International Classification of Diseases (ICD)\/cause of death. (2025). Accessed: February 16, 2026: https:\/\/www.who.int\/standards\/classifications\/classification-of-diseases\/cause-of-death."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.031484","article-title":"Trends and disparities in cardiovascular death in sarcoidosis: a population-based retrospective study in the United States from 1999 to 2020","volume":"13","author":"Tan MC","year":"2024","unstructured":"Tan MC, Yeo YH, Mirza N, et al.. Trends and disparities in cardiovascular death in sarcoidosis: a population-based retrospective study in the United States from 1999 to 2020. J Am Heart Assoc. 2024, 13:e031484. 10.1161\/JAHA.123.031484","journal-title":"J Am Heart Assoc"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13237463","article-title":"Nationwide cross-sectional analysis of mortality trends in patients with sarcoidosis and non-ischemic cardiovascular disease-the impact of gender, ethnicity, geographical location, and COVID-19 pandemic","volume":"13","author":"Ahmed R","year":"2024","unstructured":"Ahmed R, Ahmed M, Khlidj Y, et al.. Nationwide cross-sectional analysis of mortality trends in patients with sarcoidosis and non-ischemic cardiovascular disease-the impact of gender, ethnicity, geographical location, and COVID-19 pandemic. J Clin Med. 2024, 13:14-6. 10.3390\/jcm13237463","journal-title":"J Clin Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1378\/chest.14-1120","article-title":"Racial difference in sarcoidosis mortality in the United States","volume":"147","author":"Mirsaeidi M","year":"2015","unstructured":"Mirsaeidi M, Machado RF, Schraufnagel D, Sweiss NJ, Baughman RP. Racial difference in sarcoidosis mortality in the United States. Chest. 2015, 147:438-49. 10.1378\/chest.14-1120","journal-title":"Chest"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-2002","article-title":"Survival in sarcoidosis-associated pulmonary hypertension: the importance of hemodynamic evaluation","volume":"138","author":"Baughman RP","year":"2010","unstructured":"Baughman RP, Engel PJ, Taylor L, Lower EE. Survival in sarcoidosis-associated pulmonary hypertension: the importance of hemodynamic evaluation. Chest. 2010, 138:1078-85. 10.1378\/chest.09-2002","journal-title":"Chest"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2013.01.258","article-title":"The impact of severe pulmonary arterial hypertension on single lung transplantation in patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis: an analysis of the UNOS Database","volume":"32","author":"Kon ZN","year":"2013","unstructured":"Kon ZN, Bittle GJ, Evans CF, Wehman PB, Griffith BP. The impact of severe pulmonary arterial hypertension on single lung transplantation in patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis: an analysis of the UNOS Database. J Heart Lung Transplant. 2013, 32:120. 10.1016\/j.healun.2013.01.258","journal-title":"J Heart Lung Transplant"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2005.042838","article-title":"Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis","volume":"61","author":"Nunes H","year":"2006","unstructured":"Nunes H, Humbert M, Capron F, et al.. Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis. Thorax. 2006, 61:68-74. 10.1136\/thx.2005.042838","journal-title":"Thorax"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1378\/chest.15-0584","article-title":"Interrelationship between sleep-disordered breathing and sarcoidosis","volume":"148","author":"Lal C","year":"2015","unstructured":"Lal C, Medarov BI, Judson MA. Interrelationship between sleep-disordered breathing and sarcoidosis. Chest. 2015, 148:1105-14. 10.1378\/chest.15-0584","journal-title":"Chest"},{"key":"ref12","article-title":"The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States","volume":"29","author":"Judson MA","year":"2012","unstructured":"Judson MA, Boan AD, Lackland DT. The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States. Sarcoidosis Vasc Diffuse Lung Dis. 2012, 29:119-27.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201010-1679OC","article-title":"Sarcoidosis-related mortality in the United States from 1988 to 2007","volume":"183","author":"Swigris JJ","year":"2011","unstructured":"Swigris JJ, Olson AL, Huie TJ, Fernandez-Perez ER, Solomon J, Sprunger D, Brown KK. Sarcoidosis-related mortality in the United States from 1988 to 2007. Am J Respir Crit Care Med. 2011, 183:1524-30. 10.1164\/rccm.201010-1679OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.36141\/svdld.v37i2.9142","article-title":"Sarcoidosis and increased risk of comorbidities and mortality in Sweden","volume":"37","author":"Larsson J","year":"2020","unstructured":"Larsson J, Graff P, Bryngelsson IL, Vihlborg P. Sarcoidosis and increased risk of comorbidities and mortality in Sweden. Sarcoidosis Vasc Diffuse Lung Dis. 2020, 37:104-35. 10.36141\/svdld.v37i2.9142","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1980.03300270058037","article-title":"Pneumonia with special reference to pneumococcus lobar pneumonia","volume":"243","author":"Finland M","year":"1980","unstructured":"Finland M. Pneumonia with special reference to pneumococcus lobar pneumonia. JAMA. 1980, 243:72-3. 10.1001\/jama.1980.03300270058037","journal-title":"JAMA"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201610-750OC","article-title":"Sarcoidosis increases risk of hospitalized infection. a population-based study, 1976-2013","volume":"14","author":"Ungprasert P","year":"2017","unstructured":"Ungprasert P, Crowson CS, Matteson EL. Sarcoidosis increases risk of hospitalized infection. a population-based study, 1976-2013. Ann Am Thorac Soc. 2017, 14:676-81. 10.1513\/AnnalsATS.201610-750OC","journal-title":"Ann Am Thorac Soc"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.36141\/svdld.v37i2.9599","article-title":"Infection prevention in sarcoidosis: proposal for vaccination and prophylactic therapy","volume":"37","author":"Syed H","year":"2020","unstructured":"Syed H, Ascoli C, Linssen CF, et al.. Infection prevention in sarcoidosis: proposal for vaccination and prophylactic therapy. Sarcoidosis Vasc Diffuse Lung Dis. 2020, 37:87-98. 10.36141\/svdld.v37i2.9599","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202002-0251ST","article-title":"Diagnosis and detection of sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline","volume":"201","author":"Crouser ED","year":"2020","unstructured":"Crouser ED, Maier LA, Wilson KC, et al.. Diagnosis and detection of sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2020, 201:e26-51. 10.1164\/rccm.202002-0251ST","journal-title":"Am J Respir Crit Care Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-1881","article-title":"Treatment of sarcoidosis-associated pulmonary hypertension. A two-center experience","volume":"135","author":"Barnett CF","year":"2009","unstructured":"Barnett CF, Bonura EJ, Nathan SD, et al.. Treatment of sarcoidosis-associated pulmonary hypertension. A two-center experience. Chest. 2009, 135:1455-61. 10.1378\/chest.08-1881","journal-title":"Chest"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1445923","article-title":"Lung fibrosis in sarcoidosis. Is there a place for antifibrotics?","volume":"15","author":"B\u0105czek K","year":"2024","unstructured":"B\u0105czek K, Piotrowski WJ. Lung fibrosis in sarcoidosis. Is there a place for antifibrotics?. Front Pharmacol. 2024, 15:1445923. 10.3389\/fphar.2024.1445923","journal-title":"Front Pharmacol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/458754-unequal-burdens-exploring-racial-differences-in-sarcoidosis-related-deaths-due-to-pulmonary-hypertension-versus-fibrosis-in-the-united-states-1999-2023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T19:34:02Z","timestamp":1771356842000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/458754-unequal-burdens-exploring-racial-differences-in-sarcoidosis-related-deaths-due-to-pulmonary-hypertension-versus-fibrosis-in-the-united-states-1999-2023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.103785","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,17]]}}}